Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCRTR1 | O43613 | 2/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.50 |
| ▸ | KCNK9 | Q9NPC2 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14244495 | 0.86 | HCRTR1 (0.47) | HCRTR1L3MBTL1MAPTMAPK1GAA | |
| SCHEMBL1985 | 0.85 | LMNA (0.55) | HCRTR1L3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL20150685 | 0.84 | ABCB1 (0.64) | HCRTR1L3MBTL1GLAMAPTMAPK1 | |
| SCHEMBL206583 | 0.84 | HCRTR1 (0.66) | HCRTR1L3MBTL1GLAMAPTMAPK1 | |
| SCHEMBL11763044 | 0.84 | HCRTR1 (0.66) | HCRTR1L3MBTL1GLAMAPTMAPK1 | |
| SCHEMBL6969031 | 0.84 | HCRTR1 (0.66) | HCRTR1L3MBTL1GLAMAPTMAPK1 | |
| Hydrochloric Acid SCHEMBL27771056 | 0.84 | LMNA (0.54) | HCRTR1L3MBTL1MAPTMEN1KMT2A | |
| SCHEMBL5827955 | 0.84 | LMNA (0.62) | L3MBTL1MAPTMAPK1MEN1KMT2A | |
| SCHEMBL27574878 | 0.84 | HCRTR1 (0.49) | HCRTR1L3MBTL1GLAMAPTMAPK1 | |
| SCHEMBL30292656 | 0.82 | LMNA (0.71) | HCRTR1L3MBTL1GLAMAPTMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 485 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117756625-B | Preparation method of o-ethoxybenzoyl chloride | 达高工业技术研究院(广州)有限公司 | 2024-06-18 | — | — | CN | claimed |
| CN-117756625-A | Preparation method of o-ethoxybenzoyl chloride | 达高工业技术研究院(广州)有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-112239653-B | Fluid loss additive for drilling fluid based on nanofiber-hydrophobic starch compound and preparation method thereof | 中石化石油工程技术服务有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-112239653-A | Fluid loss additive for drilling fluid based on nanofiber-hydrophobic starch compound and preparation method thereof | 中石化石油工程技术服务有限公司 | 2021-01-19 | — | — | CN | claimed |
| CN-111548263-A | Process method for preparing o-ethoxy benzoyl chloride | 江苏巨莱生物医药有限公司 | 2020-08-18 | — | — | CN | claimed |
| CN-111116591-A | Method for preparing sildenafil citrate | 天津科伦药物研究有限公司 | 2020-05-08 | — | — | CN | claimed |
| US-9512242-B2 | Polymerizable oligomer and photoresist composition comprising the same | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2016-12-06 | — | — | US | claimed |
| CN-104194398-B | Fluorescent dichroic dye containing 4- (p-hydroxypiperidinyl) -1, 8-naphthaline dinitrile, preparation method and application thereof | DALIAN UNIVERSITY OF TECHNOLOGY (CN) | 2016-06-01 | — | — | CN | claimed |
| US-20160137758-A1 | POLYMERIZABLE OLIGOMER AND PHOTORESIST COMPOSITION COMPRISING THE SAME | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2016-05-19 | — | — | US | claimed |
| CN-104194398-A | Fluorescent dichroic dye containing 4- (p-hydroxypiperidinyl) -1, 8-naphthaline dinitrile, preparation method and application thereof | UNIV DALIAN TECH | 2014-12-10 | — | — | CN | claimed |
| WO-2006127368-A2 | METHODS FOR SYNTHESIZING IMIDAZOTRIAZINONES | LEXICON GENETICS INCORPORATED (US) | 2006-11-30 | — | — | WO | claimed |
| US-20060264624-A1 | Methods for synthesizing imidazotriazinones | LEXICON GENETICS INCORPORATED | 2006-11-23 | — | — | US | claimed |
| US-4362510-A | ESTER OF VANILLIC ACID, METAL OXIDE OR HYDROXIDE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1982-12-07 | — | — | US | claimed |
| CN-117777023-B | Preparation method and application of aminopyrazole compound | 山东特珐曼药业有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-121955254-A | Method for detecting 2-ethoxybenzoyl chloride and related substances thereof | 广药白云山化学制药(珠海)有限公司 | 2026-05-01 | — | — | CN | disclosed |
| CN-121955254-A | Method for detecting 2-ethoxybenzoyl chloride and related substances thereof | 广药白云山化学制药(珠海)有限公司 | 2026-05-01 | — | — | CN | disclosed |
| CN-1057464-A | Pyrazolopyrimidinoneantianginal antianginal agents | PFIZER (US) | 1992-01-01 | — | — | CN | disclosed |
| US-4058523-A | ANTIULCER, VASODILATION, HYPOTENSIVE, ANALGESIC | CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) | 1977-11-15 | — | — | US | disclosed |
| US-3953496-A | ANTIPYRETICS, ANTI-ALLERGIC, ANTI-INFLAMMATORY AGENTS | CHUGAI SEIYAKU KABUSHIKI KAISHA (JA) | 1976-04-27 | — | — | US | disclosed |
| US-3939162-A | Anthrapyrimidine dyes | BASF AKTIENGESELLSCHAFT (DT) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060264624-A1 | Methods for synthesizing imidazotriazinones | PDE3A, PDE2A, PDE3B | HCRTR1 4355/4885L3MBTL1 4829/4885GLA 1797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.